Safety of the ORBCEL-C therapy (MSCs derived from umbilical cord tissue) in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19
Latest Information Update: 14 Apr 2020
At a glance
- Drugs Orbcel-C (Primary)
- Indications Adult respiratory distress syndrome
- Focus Therapeutic Use
- Acronyms REALIST COVID-19
Most Recent Events
- 14 Apr 2020 New trial record
- 07 Apr 2020 Accordding to a Queens University media release, this study is funded by the Health and Social Care Research & Development Division and the Wellcome Trust, sponsored by the Belfast Health and Social Care Trust and supported by the NI Clinical Trials Unit, the NIHR Clinical Research Network and the Northern Ireland Clinical Research Network.
- 07 Apr 2020 Accordding to a Queens University media release, first patient has now been recruited with plans to recruit at least 60 patients throughout the COVID-19 pandemic at multiple sites across the UK including Belfast, Birmingham and London.